Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM) company and a leader in clinical genomic testing, announced today that a peer-reviewed study validating the accuracy of ...

What infrastructure is needed to realise the potential of AI in health and care? This long read considers the technical, environmental and system capabilities required.